EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Real‐world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational study

Chika Ohata iD, Hisataka Anezaki, Tetsuji Yanase iD, Eri Katayama, Sakae Kaneko iD, Kanami Saito iD, Mariko Yamane iD, Sei Nakamaru, Noriko Tsuruta iD, Fusako Okazaki, Kotaro Ito, Satoko Kikuchi und 13 weitere

The Journal of Dermatology · 2024

DOI: 10.1111/1346-8138.17385 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Dermatology, 2024. Verfasst von Chika Ohata und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Osaka General Medicine Center, Osaka, Japan. Hauptthemen laut MEDLINE: Psoriasis, Biological Products, Registries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical trials of biologics have frequently excluded elderly patients, resulting in inadequate data on their safety and efficacy. Additionally, evidence of their safety and efficacy remains limited, despite some real‐world studies. To assess the safety and efficacy of biologics in elderly patients with psoriasis, we compared these outcomes in younger patients using data from the West Japan Psoriasis Registry (WJPR). The WJPR consists of approximately 30 facilities in Western Japan, including various healthcare settings. This study enrolled 1395 patients who participated in the 2022 follow‐up survey of the WJPR and were either using or had used biologics during the survey. These included 456 patients in the elderly group (≥65 years) and 939 patients in the younger group (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisBiological ProductsRegistriesHumansMaleFemaleAgedJapanMiddle AgedAge FactorsTreatment OutcomeAdultIncidenceFollow-Up StudiesSeverity of Illness IndexDermatologic AgentsNeoplasms

Stichwörter der Autor:innen

efficiencyelderly patientsinfectionpsoriasissafety

Substanzen

Biological ProductsDermatologic Agents

Autor:innen und Institutionen

  • Department of Dermatology, Osaka General Medicine Center, Osaka, Japan.
  • Social/Community Medicine and Health Science, Graduate School of Medicine Kobe University, Kobe, Japan.
  • Kamiyacho Yanase Dermatology Clinic, Hiroshima, Japan.
  • Department of Dermatology, Hiroshima City North Medical Center Asa Citizens Hospital, Hiroshima, Japan.
  • Department of Dermatology, Kurume University School of Medicine, Kurume, Japan.
  • Department of Dermatology, Masuda Red Cross Hospital, Masuda, Japan.

ORCID-Profile: Chika Ohata, Tetsuji Yanase, Sakae Kaneko, Kanami Saito, Mariko Yamane, Noriko Tsuruta, Yuta Koike, Takuya Miyagi, Hiroshi Saruwatari, Kentaro Yonekura, Yu Sawada, Shinichi Imafuku

Zitieren

APA

Ohata, C., Anezaki, H., Yanase, T., Katayama, E., Kaneko, S., Saito, K., Yamane, M., Nakamaru, S., Tsuruta, N., Okazaki, F., Ito, K., Kikuchi, S., Koike, Y., Miyagi, T., Sugita, K., Nakahara, T., Takezaki, D., Saruwatari, H., Yoshida, Y., …, & Imafuku, S. (2024). Real‐world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational study. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17385

Vancouver

Ohata C, Anezaki H, Yanase T, Katayama E, Kaneko S, Saito K, et al. Real‐world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational study. The Journal of Dermatology. 2024. doi:10.1111/1346-8138.17385

BibTeX
@article{Ohata2024,
  author = {Ohata, Chika and Anezaki, Hisataka and Yanase, Tetsuji and Katayama, Eri and Kaneko, Sakae and Saito, Kanami and Yamane, Mariko and Nakamaru, Sei and Tsuruta, Noriko and Okazaki, Fusako and Ito, Kotaro and Kikuchi, Satoko and Koike, Yuta and Miyagi, Takuya and Sugita, Kazunari and Nakahara, Takeshi and Takezaki, Daiki and Saruwatari, Hiroshi and Yoshida, Yuichi and Yonekura, Kentaro and Higashi, Yuko and Sawada, Yu and Chinuki, Yuko and Yamaguchi, Kazuki and Imafuku, Shinichi},
  title = {Real‐world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational study},
  journal = {The Journal of Dermatology},
  year = {2024},
  doi = {10.1111/1346-8138.17385}
}
Kostenlos starten →